Filgrastim-sndz Clinical Trials

2 actively recruiting trials across 1 location

Also known as: Filgrastim Biosimilar Filgrastim-sndz, Zarxio

Pipeline

Phase 2: 1Phase 1/2: 1

Top Sponsors

M.D. Anderson Cancer Center2

Indications

Cancer2
t(8;21)1
t(16;16)1
Inv(16)1
Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T11

Houston, Texas2 trials

Bendamustine With or Without Cyclophosphamide in Preventing GVHD in Patients Undergoing Stem Cell Transplant

M D Anderson Cancer Center

Phase 1/2

Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

M D Anderson Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.